MIRA INFORM REPORT

 

 

Report No. :

307752

Report Date :

17.02.2015 

 

IDENTIFICATION DETAILS

 

Name :

RA CHEM PHARMA LIMITED (w.e.f. 16.05.2005)

 

 

Formerly Known As :

IGOR PHARMACEM LIMITED

IGOR PHARMACEM PRIVATE LIMITED

IGOR DYESPEC PRIVATE LIMITED

 

 

Registered Office :

Plot No.26 and 27, Technocrats Industrial Estate, Phase I, Balangar, Hyderabad – 500 037, Telangana

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

08.01.1996

 

 

Com. Reg. No.:

36-022816

 

 

Capital Investment / Paid-up Capital :

Rs.100.181 millions

 

 

CIN No.:

[Company Identification No.]

U24110AP1996PLC022816

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

HYDI00508E

 

 

PAN No.:

[Permanent Account No.]

AAACI6448M

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Subject is engaged in the manufacturing of Active Pharmaceutical Ingredients (API), Formulations and Clinical Research Activity. 

 

 

No. of Employees :

Information declined by the Management.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (34)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track record.

 

As per registrar of companies the date of balance sheet (i.e. financial file) is shown as 31.03.2014 but the document related to the financial for the 2013 and 2014 could not be made available from any source.

 

As per previous financial record of 2012, general financial positon of the company seems to be sound. 

 

However, trade relations are fair. Business is active. Payments are reported to be slow but correct.

 

The company can be considered for business dealings with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CARE

Rating

Long Term Bank Facilities = BBB-

Rating Explanation

Moderate degree of safety and moderate credit risk

Date

28.10.2014

 

 

Rating Agency Name

CARE

Rating

Short Term Bank Facilities = A3

Rating Explanation

Moderate degree of safety and high credit risk

Date

28.10.2014

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

INFORMATION DECLINED BY

 

Name :

Mr. Jagan Nath Rao 

Designation :

Purchase Manager

Contact No.:

91-8008277892

Date :

14.02.2014

           


 

LOCATIONS

 

Registered Office/ Corporate Office/ Clinical Research and Biosciences Department :

Plot No.26 and 27, Technocrats Industrial Estate, Phase I, Balangar, Hyderabad – 500 037, Telangana, India

Tel. No.:

91-40-44758595

Mobile No.:

91-9652216217 (Mr. Ananta Kanango)

91-8008277892 (Mr. Jagan Nath Rao )

Fax No.:

91-40-44758596

E-Mail :

info@rachempharma.com

raj@rachempharma.com

rmpurchase@invetisdds.com

Website:

http://www.rachempharma.com

 

 

Manufacturing Facility (API) :

R.S. No.50/1, Mukteswarapuram Jaggaiahpeta Mandal, District Krishna – 521 175, Andhra Pradesh, India

Tel No.:

91-8683-240802/ 240803

E mail:

factory@rachemicals.com

 

 

Manufacturing Facility and R&D (FDF) Department :

Plot No:A-19/C, Road No: 18, IDA, Nacharam, Hyderabad – 500 076, Telangana, India

 

 

Formulation R&D Department :

4th Floor, CDC Towers, Road No: 5, IDA, Nacharam, Hyderabad – 500 076, Telangana, India

 

 

API R&D Department :

5-5-35/69, Ayyanna Building, Prashant Nagar, Kukatpally, Hyderabad – 500 072
Telangana, India

 

 

DIRECTORS

 

AS ON 29.09.2014

 

Name :

Mr. Rajender Rao Juvvadi

Designation :

Managing Director

Address :

8-2-686/6/D1, Road No. 12, Banjara Hills, Hyderabad – 500 034, Telangana, India

Date of Birth/Age :

20.11.1967

Date of Appointment :

14.03.2003

PAN No.:

ABNPJ8965B

DIN No.:

00083540

Other Directorship:

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U67120TG1999PTC033145

LAXMI R.A. HOLDINGS AND INVESTMENTS PRIVATE LIMITED

Director

16/10/2001

16/10/2001

-

Active

NO

2

U24110AP1996PLC022816

RA CHEM PHARMA LIMITED

Managing director

14/03/2003

14/03/2003

-

Active

NO

3

U99999TG2000PTC035037

R.A.LABELS AND STICKERS PRIVATE LIMITED

Director

01/04/2004

01/04/2004

-

Active

NO

4

U24239TG2003PTC040264

INVENTIS DRUG DELIVERY SYSTEMS PRIVATE LIMITED

Director

10/07/2004

10/07/2004

-

Amalgamated

NO

5

U24239TG2006PTC050152

CLINICAL RESEARCH AND BIOSCIENCES INDIA PRIVATE LIMITED

Director

19/05/2006

19/05/2006

-

Amalgamated

NO

6

U24239TG2004PTC043904

INDU PHARMA PRIVATE LIMITED

Director

08/01/2007

08/01/2007

-

Active

NO

7

U65910TG2010PTC066795

BEANSTALK INVESTMENT CONSULTANTS PRIVATE LIMITED

Director

25/01/2010

25/01/2010

01/02/2014

Active

NO

8

U24232TG2012PTC081598

EPIONE LABS PRIVATE LIMITED

Director

01/03/2014

01/03/2014

-

Active

NO

9

U24232TG2014PTC096432

GENESYS BIOLOGICS PRIVATE LIMITED

Director

18/11/2014

18/11/2014

-

Active

NO

10

U24232TG2014PTC096589

AMICUS FORMULATIONS INDIA PRIVATE LIMITED

Director

28/11/2014

28/11/2014

-

Active

NO

 

 

Name :

Mr. Sirish Kumar Ravula

Designation :

Director

Address :

253/3RT, Vijaya Nagar Colony, Hyderabad – 500 057, Telangana, India

Date of Birth/Age :

08.07.1965

Date of Appointment :

10.03.2003

PAN No.:

ACZPR6294C

DIN No.:

01578978

Other Directorship:

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24110AP1996PLC022816

RA CHEM PHARMA LIMITED

Director

10/03/2003

10/03/2003

-

Active

NO

2

U67120TG1999PTC033145

LAXMI R.A. HOLDINGS AND INVESTMENTS PRIVATE LIMITED

Director

19/05/2003

19/05/2003

-

Active

NO

3

U24239TG2003PTC040264

INVENTIS DRUG DELIVERY SYSTEMS PRIVATE LIMITED

Director

02/11/2004

02/11/2004

-

Amalgamated

NO

4

U24239TG2006PTC050152

CLINICAL RESEARCH AND BIOSCIENCES INDIA PRIVATE LIMITED

Director

19/05/2006

19/05/2006

-

Amalgamated

NO

5

U24239TG2004PTC043904

INDU PHARMA PRIVATE LIMITED

Director

02/08/2006

02/08/2006

-

Active

NO

6

U24232TG2012PTC081598

EPIONE LABS PRIVATE LIMITED

Director

01/03/2014

01/03/2014

-

Active

NO

 

 

Name :

Mr. Ravi Kumar Yerra

Designation :

Director

Address :

Flat #02, Jubilee Heavens, 104, Womens Co-operative Housing Society, Jubilee Hills, Hyderabad – 500 033, Telangana, India

Date of Birth/Age :

05.03.1961

Date of Appointment :

01.10.2005

PAN No.:

AAYPY5116H

DIN No.:

01941752

Other Directorship:

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24110AP1996PLC022816

RA CHEM PHARMA LIMITED

Director

01/10/2005

01/10/2005

-

Active

NO

2

U67120TG1999PTC033145

LAXMI R.A. HOLDINGS AND INVESTMENTS PRIVATE LIMITED

Director

01/02/2006

01/02/2006

-

Active

NO

3

U24239TG2004PTC043904

INDU PHARMA PRIVATE LIMITED

Director

01/06/2011

01/06/2011

-

Active

NO

 

 

Name :

Dr. Battula Srinivasa Reddy

Designation :

Director

Address :

310, Srinilaya Apartment, Yellareddyguda, Hyderabad, Telangana, India

Date of Birth/Age :

01.07.1966

Date of Appointment :

31.12.2003

PAN No.:

ACSPB6668D

DIN No.:

02878853

Other Directorship:

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24110AP1996PLC022816

RA CHEM PHARMA LIMITED

Director

31/12/2003

14/03/2003

-

Active

NO

2

U67120TG1999PTC033145

LAXMI R.A. HOLDINGS AND INVESTMENTS PRIVATE LIMITED

Director

20/12/2004

20/12/2004

-

Active

NO

 

Name :

Mr. Harcharan Mohan Singh

Designation :

Nominee Director

Address :

10 WaterLoo Crt, Thorn Hill, On Thorn Hill, Canada

Date of Birth/Age :

19.05.1945

Date of Appointment :

15.02.2012

DIN No.:

02852915

Other Directorship:

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24230GJ1984PLC007440

CONCORD BIOTECH LIMITED

Director

14/09/2010

04/12/2009

-

Active

NO

2

U51101TG2010PTC071300

GLOPEC INTERNATIONAL (INDIA) PRIVATE LIMITED

Director

22/11/2010

22/11/2010

-

Active

NO

3

U24110AP1996PLC022816

RA CHEM PHARMA LIMITED

Nominee director

15/02/2012

15/02/2012

-

Active

NO

 

 

KEY EXECUTIVES

 

Name :

Mr. Jagan Nath Rao 

Designation :

Purchase Manager

 

 

MAJOR SHAREHOLDERS

 

AS ON 29.09.2014

 

Names of Shareholders

 

 

No. of Shares

Laxmi RA Holdings and Investment Private Limited, India

 

4166186

1575773 Ontario Inc., Canada

 

1894023

Orchem International Trading BV, The Netherland

 

511397

Anand Gupta

 

699422

Laxman Kartikeyan

 

46023

Joflo Centrifuges Private Limited, India

 

652527

Joseph Herman

 

360000

N Nageswar Rao

 

3575

Harish Pandey

 

67071

P V Shedbalkar

 

100881

Total

 

8501105

 

 

Equity Share Break up (Percentage of Total Equity)

 

AS ON 29.09.2014

 

Category

Percentage

Foreign holdings [(Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others]

33.07

Bodies corporate

56.68

Other top fifty shareholders

10.25

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Subject is engaged in the manufacturing of Active Pharmaceutical Ingredients (API), Formulations and Clinical Research Activity. 

 

 

Products :

Products Description

 

ITC Code

Other Diloxanide Furoate, Cimetidine, Famotidine Nesglands and Other Organs for Organotherapeutic uses, Dried, whether or not

29420090

 

 

Brand Names :

Not Divulged

 

 

Agencies Held :

Not Divulged

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

Not Divulged

 

PRODUCTION STATUS NOT AVAILABLE


 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

Customers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

No. of Employees :

Information denied by the Management.

 

 

Bankers :

·        ICICI Bank Limited, Landmark Race Cource Circle, Alkapuri, Vadodara – 390 015, Gujarat, India

·        State Bank of India, IFB, Raj Bhavan Road, Somajiguda, Hyderabad – 500 081, Telangana, India

·         Yes Bank Limited, 9th Floor, Nehru Centre, Discover of India, Dr. Annie Besant Road, Worli, Mumbai – 400 018, Maharashtra, India

·         Bank of Bahrain and Kuwait BSC, 6-3-550, L.B. Bhawan, Akash Ganga, Somajiguda, Hyderabad – 500 082, Telangana, India

·         State Bank of India, Saifabad (SIB) Branch, HACA Bhavan, Opposite Assembly, Hyderabad – 500 004, Telangana, India

·         Axis Bank Limited, 6-3-879/B, Greenlands Road, Begumpet, Hyderabad – 500 016, Telangana, India

·         ICICI Bank Limited, 1-11-256, Begumpet, Level IV, Hyderabad – 500 016, Telangana, India

·         Barclays Bank PLC, 20-21, Kamaraj Salai, Kanchipuram – 631 501, Tamilnadu, India

 

 

Facilities :

SECURED LOANS

31.03.2012

Rs. In Millions

31.03.2011

Rs. In Millions

LONG TERM BORROWINGS

 

 

Rupee term loans from banks

68.821

0.000

Foreign currency term loans from banks

120.194

83.988

Other external commercial borrowings

87.861

85.754

Loans taken for fixed assets

2.358

3.842

Total

279.234

173.584

 

Banking Relations :

--

 

 

Financial Institutions :

·         3i Infotech Trusteeship Services Limited, 3rd to 6th Floor, International Infotech Park, Tower No.5, Vashi Railway Station Complex, Vashi, Navi Mumbai – 400 703, Maharashtra, India

·         SREI Equipment Finance Private Limited, ‘Vishwakarma’, 86C, Topsia Road, Kolkata – 700 046, West Bengal, India

 

 

Auditors :

 

Name :

Chakradhar and Nandan

Chartered Accountants

Address :

201, Srinath Residential Complex, SD Road, Secunderabad – 500 003, Telangana, India

Tel. No.:

91-40-66317174/ 66317598

E-Mail :

chakradhar_nandan@yahoo.com

PAN No.:

AABFC2045G

 

 

Holding Company :

·         Laxmi R.A. Holdings and Investments Private Limited

CIN No.: U67120AP1999PTC033145

 

 

Subsidiary Company :

·         Indu Pharma Private Limited

CIN No.: U24239AP2004PTC043904

 

 

Enterprises which are owned, or have significant influence of or are partners with Key management personnel and their relatives :

·         R.A. Labels and Stickers Private Limited

CIN No.: U99999AP2000PTC035037

 

 

CAPITAL STRUCTURE

 

AS ON 29.09.2014

Authorised Capital :

No. of Shares

Type

Value

Amount

14000000

Equity Shares

Rs.10/- each

Rs.140.000 millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

8501105

Equity Shares

Rs.10/- each

Rs.85.011 millions

 

 

 

 

 

AS ON 31.03.2012

Authorised Capital :

No. of Shares

Type

Value

Amount

10000000

Equity Shares

Rs.10/- each

Rs.100.000 millions

400000

Preference shares

Rs.100/- each

Rs.40.000 millions

 

Total

 

Rs.140.000 millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

8018125

Equity Shares

Rs.10/- each

Rs.80.181 millions

200000

Preference shares

Rs.100/- each

Rs.20.000 millions

 

Total

 

Rs.100.181 millions

 

 

 

 

 

 

 


FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1) Shareholders' Funds

 

 

 

(a) Share Capital

 

100.181

134.928

(b) Reserves & Surplus

 

489.916

312.586

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

590.097

447.514

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

 

303.743

202.573

(b) Deferred tax liabilities (Net)

 

35.727

8.042

(c) Other long term liabilities

 

0.000

0.000

(d) Long-term provisions

 

3.346

1.957

Total Non-current Liabilities (3)

 

342.816

212.572

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

438.338

226.039

(b) Trade payables

 

396.953

339.260

(c) Other current liabilities

 

118.794

141.655

(d) Short-term provisions

 

64.168

18.922

Total Current Liabilities (4)

 

1018.253

725.876

 

 

 

 

TOTAL

 

1951.166

1385.962

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

683.621

537.488

(ii) Intangible Assets

 

4.171

8.117

(iii) Capital work-in-progress

 

49.249

22.400

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

9.744

9.744

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

0.000

0.000

(e) Other Non-current assets

 

0.000

0.000

Total Non-Current Assets

 

746.785

577.749

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

410.074

248.560

(c) Trade receivables

 

574.674

401.937

(d) Cash and cash equivalents

 

32.416

22.822

(e) Short-term loans and advances

 

187.217

134.894

(f) Other current assets

 

0.000

0.000

Total Current Assets

 

1204.381

808.213

 

 

 

 

TOTAL

 

1951.166

1385.962

 

 

SOURCES OF FUNDS

 

 

 

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

134.928

2] Share Application Money

 

 

0.000

3] Reserves & Surplus

 

 

241.484

4] (Accumulated Losses)

 

 

0.000

NETWORTH

 

 

376.412

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

383.565

2] Unsecured Loans

 

 

36.622

TOTAL BORROWING

 

 

420.187

DEFERRED TAX LIABILITIES

 

 

0.377

 

 

 

 

TOTAL

 

 

796.976

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

453.906

Capital work-in-progress

 

 

6.770

Research and Development

 

 

8.580

 

 

 

 

INVESTMENT

 

 

9.744

DEFERREX TAX ASSETS

 

 

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 

 

201.605

 

Sundry Debtors

 

 

311.771

 

Cash & Bank Balances

 

 

24.478

 

Other Current Assets

 

 

90.276

 

Loans & Advances

 

 

0.000

Total Current Assets

 

 

628.130

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

 

 

250.452

 

Other Current Liabilities

 

 

42.326

 

Provisions

 

 

18.032

Total Current Liabilities

 

 

310.810

Net Current Assets

 

 

317.320

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

0.656

 

 

 

 

TOTAL

 

 

796.976

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Income

1742.034

1107.351

918.510

 

 

Other Income

6.366

3.105

3.108

 

 

TOTAL                                         (A)

1748.400

1110.456

921.618

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

910.234

609.358

 

 

 

Purchase of Stock-in-trade

37.942

22.085

 

 

 

Changes in Inventories of finished goods, work-in-progress and stock-in-trade

(99.544)

(49.120)

 

 

 

Employee Benefits Expenses

145.242

105.120

 

 

 

Other Expenses

414.597

256.170

 

 

 

TOTAL                                         (B)

1408.471

943.613

775.751

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

339.929

166.843

145.867

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

60.979

40.828

42.899

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                (E)

278.950

126.015

102.968

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION                     (F)

44.514

31.071

27.198

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX (E-F)                  (G)     

234.436

94.944

75.770

 

 

 

 

 

Less

TAX                                                                  (H)

91.854

23.842

12.181

 

 

 

 

 

 

PROFIT/ (LOSS) AFTER TAX (G-H)                   (I)

142.582

71.102

63.589

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

175.078

103.976

40.387

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

317.660

175.078

103.976

 

 

 

 

 

 

Earnings Per Share (Rs.)

17.78

9.49

8.49

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

Net Profit Margin
(PAT / Sales)

(%)

8.18

6.42

6.92

 

 

 

 

 

Operating Profit Margin
(PBIDT/Sales)

(%)

19.51

15.07

15.88

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

12.39

7.01

16.69

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.40

0.21

0.20

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

1.26

0.96

1.12

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.18

1.11

2.02

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2010

31.03.2011

31.03.2012

 

Rs. In Millions

Rs. In Millions

Rs. In Millions

Share Capital

134.928

134.928

100.181

Reserves & Surplus

241.484

312.586

489.916

Net worth

383.565

173.584

279.234

 

36.622

255.028

462.847

Secured Loans

420.187

428.612

742.081

Unsecured Loans

1.116

0.958

1.258

Total borrowings

383.565

173.584

279.234

Debt/Equity ratio

36.622

255.028

462.847

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2010

31.03.2011

31.03.2012

 

Rs. In Millions

Rs. In Millions

Rs. In Millions

Sales

918.510

1,107.351

1,742.034

 

 

20.559

57.315

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2010

31.03.2011

31.03.2012

 

Rs. In Millions

Rs. In Millions

Rs. In Millions

Sales

918.510

1,107.351

1,742.034

Profit

63.589

71.102

142.582

 

6.92%

6.42%

8.18%

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

----------

22]

Litigations that the firm / promoter involved in

----------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------

26]

Buyer visit details

----------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

No

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

Note:

The registered office of the company has been shifted from 6-3-1239/2, “Amar”, 4th Floor, Raj Bhavan Road, Somajiguda, Hyderabad – 500 082, Andhra Pradesh to the present address w.e.f. 19.11.2009.

 

 

UNSECURED LOANS:

 

Particulars

31.03.2012

Rs. In Millions

31.03.2011

Rs. In Millions

LONG TERM BORROWINGS

 

 

Intercorporate borrowings

23.406

27.255

Deposits from directors

1.103

0.000

Loans and advances from related parties

0.000

1.471

Other loans and advances

0.000

0.263

SHORT TERM BORROWINGS

 

 

Rupee term loans from others

0.657

2.433

Loans repayable on demand

437.681

223.606

Total

462.847

255.028

 

INDEX OF CHARGES:

 

S. No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10545392

06/01/2015

245,000,000.00

ICICI BANK LIMITED

LANDMARKRACE COURCE CIRCLE, ALKAPURI, BARODA, GUJARAT - 390015, INDIA

C41584020

2

10443975

27/06/2013

225,000,000.00

STATE BANK OF INDIA

SAIFABAD (SIB) BRANCH, HACA BHAVAN, OPPOSITE ASSEMBLY, 
HYDERABAD, ANDHRA PRADESH - 500004, INDIA

B82532599

3

10443980

27/06/2013

225,000,000.00

STATE BANK OF INDIA

SAIFABAD (SIB) BRANCH, HACA BHAVAN, OPPOSITE ASSEMBLY, 
HYDERABAD, ANDHRA PRADESH - 500004, INDIA

B82535337

4

10357644

16/04/2012

2,123,604.00

AXIS BANK LIMITED

5-2-183/184,ASC CENTRE, III FLOOR, R P ROAD, HYDERABAD, ANDHRA PRADESH - 500003, INDIA

B40388639

5

10327698

30/07/2014 *

1,420,000,000.00

STATE BANK OF INDIA

IFB, RAJ BHAVAN ROAD, SOMAJIGUDA, HYDERABAD, TELANGANA - 500081, INDIA

C15220023

6

10304109

03/06/2013 *

780,100,000.00

STATE BANK OF INDIA

SAIFABAD (SIB) BRANCH, HACA BHAVAN, OPPOSITE ASSEMBLY, 
HYDERABAD, ANDHRA PRADESH - 500004, INDIA

B79906806

7

10228628

11/06/2010

25,000,000.00

BANK OF BAHRAIN AND KUWAIT BSC

6-3-550, L.B. BHAWAN, AKASH GANGA, SOMAJIGUDA, 
HYDERABAD, ANDHRA PRADESH - 500082, INDIA

A88931647

8

10219143

01/10/2010 *

301,900,000.00

STATE BANK OF INDIA

SAIFABAD BRANCH HACA BHAVAN, OPP ASSEMBLY, HYDERABAD, ANDHRA PRADESH - 500004, INDIA

A98290042

9

10079977

19/11/2007 *

42,500,000.00

STATE BANK OF INDIA

SAIFABAD (SIB) BRANCH, HACA BHAVAN, SAIFABAD, HYDEARABAD, ANDHRA PRADESH - 500004, INDIA

A30101455

10

10073795

29/09/2009 *

45,500,000.00

ICICI BANK LIMITED

LANDMARKRACE COURCE CIRCLE, ALKAPURI, BARODA, GUJARAT - 390015, INDIA

A71992390

11

90263340

11/04/2007 *

96,400,000.00

ANDHRA PRADESH STATE FINANCIAL CORPORATION

5-9-194, CHIRAG ALI LANE, P B NO. 165, HYDERABAD, 
ANDHRA PRADESH - 500001, INDIA

A13305354

12

90117611

26/03/2002 *

34,500,000.00

STATE BANK OF INDIA

OVERSEAS BRANCH, 5-9-300; ABIDS, HYDERABAD, ANDHRA PRADESH - 500001, INDIA

-

 

*Date of modification Charges

 

 

FIXED ASSETS:

 

·         Land

·         Building

·         Plant and Machinery

·         Computer

·         Vehicles

·         Furniture and Fixture


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :  No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.20

UK Pound

1

Rs.95.99

Euro

1

Rs.71.00                                  

 

 

INFORMATION DETAILS

 

Information Gathered by :

GYT

 

 

Analysis Done by :

KAR

 

 

Report Prepared by :

SMN

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

-- PROFITABILITY

1~10

4

--LIQUIDITY

1~10

4

--LEVERAGE

1~10

3

--RESERVES

1~10

4

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

34

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.